IPO, Ascentage

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics
Ascentage prices first biotech IPO of 2025, raising $126M
The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
Rockville's Ascentage Pharma seeks to raise $134M in U.S. IPO
A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s US trading debut, after pricing its $126.4 million initial public offering at a discount to its Asian stock.
Ascentage Pharma IPO opens flat
IPO began trading Friday on the NASDAQ. Shares opened at $17.25 per ADS, in line with the initial public offering (IPO) price of $17.25. The pharmaceutical company, already listed on the Main Board of the Stock Exchange of Hong Kong Limited under the code 6855.
Takeda-backed Ascentage Pharma prices $126M U.S. IPO
Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced a $126M U.S. initial public offering. The China-based drug developer priced 7.33M shares at $17.25 per share,
FierceBiotech2d
GSK, Merck and Pfizer in Ab&B's sights as Chinese vaccine biotech files for IPO
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
阿思達克財經網3d
Bonnie Chan: HK IPO Mkt Continues to Recover w/ ~100 IPOs under Preparation
With Hong Kong's IPO market showing a good recovery in 2024 and more stimulus measures launched by China since September 2024 ...
U.S. IPO Weekly Recap: Venture Global Prices A Pared-Down IPO As More Sizable Deals Join The Pipeline
Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.
Chinese soda maker Dayao plans Hong Kong IPO to raise up to US$500 million
The Inner Mongolia-based maker of carbonated beverages, juices and protein drinks is working with advisers on the size and ...
Bain-Backed Sustainable Fuel Producer EcoCeres Eyes Europe IPO
EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...
Phoenix Asia Holdings Targets IPO On Sky-High Valuation
Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...
Opening Day: LNG player Venture Global opens below reduced IPO price
Venture Global’s stock fell about 4% below its initial public offering price in its market debut on Friday, after the liquefied natural gas ...